# NJEDA Awards Piscataway Manufacturing Tax Credits

On October 26, 2026, the New Jersey Economic Development Authority (NJEDA) approved **$60.56 million in tax credits over five years** for Amneal Pharmaceuticals’ planned manufacturing expansion in Piscataway. Amneal expects to invest more than $240 million over three years, renovate eight buildings into an integrated manufacturing campus, and create more than 330 full-time jobs. The award is an economic incentive, not a contract solicitation or RFP; however, the expansion may create downstream demand for building renovation, manufacturing equipment, quality control, and logistics services.

- Contractors and suppliers in those areas can assess whether their capabilities align with the planned campus expansion; no specific procurement, solicitation, or award to contractors has been announced.
- The project’s scale and multiyear investment may be relevant to businesses planning capacity and outreach for pharmaceutical manufacturing and facility-related work in New Jersey.
- The NJEDA identified business resources through Customer Care at 844-965-1125; the signal does not provide a project procurement contact or bidding process.

**Jurisdictions:** sled
**Industries:** Healthcare, Construction & Infrastructure
**Topics:** Grants & Funding
**Published:** October 26, 2026

### Government Entities
- New Jersey Economic Development Authority (NJEDA)

### Vendors
- Amneal Pharmaceuticals (Tax-credit award recipient and planned project developer)

### Sources
- [NJEDA Approves Next New Jersey Manufacturing Award to Support Amneal Pharmaceuticals’ New Jersey Expansion - NJEDA](https://www.njeda.gov/njeda-approves-next-new-jersey-manufacturing-award-to-support-amneal-pharmaceuticals-new-jersey-expansion/) - NJ